Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease

References

• Gladwin MT, Sachdev V, Jison ML et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med.350(9), 886–895 (2004).
   PubMed Web of Science ®Google Scholar
• Sachdev V, Kato GJ, Gibbs JS et al. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation124(13), 1452–1460 (2011).
   PubMedGoogle Scholar
• Sachdev V, Machado RF, Shizukuda Y et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J. Am. Coll. Cardiol.49(4), 472–479 (2007).
   PubMed Web of Science ®Google Scholar
• Machado RF, Anthi A, Steinberg MH et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA296(3), 310–318 (2006).
   PubMed Web of Science ®Google Scholar
• Machado RF, Hildescheim M, Mendelsohn L, Kato GJ, Gladwin MT. NT-pro brain natriuretic peptide levels and the risk of stroke and death in the cooperative study of sickle cell disease. Blood114, 1541 (2009).
   Google Scholar
• Ataga KI, Moore CG, Jones S et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br. J. Haematol.134(1), 109–115 (2006).
   PubMed Web of Science ®Google Scholar
• De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am. J. Hematol.83(1), 19–25 (2008).
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N. Engl. J. Med.359(21), 2254–2265 (2008).
   PubMed Web of Science ®Google Scholar
• Reiter CD, Wang X, Tanus-Santos JE et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med.8(12), 1383–1389 (2002).
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA293(13), 1653–1662 (2005).
   PubMed Web of Science ®Google Scholar
• Morris CR, Kato GJ, Poljakovic M et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA294(1), 81–90 (2005).
   PubMed Web of Science ®Google Scholar
• Donadee C, Raat NJ, Kanias T et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation124(4), 465–476 (2011).
   PubMed Web of Science ®Google Scholar
• Bunn HF, Nathan DG, Dover GJ et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood116(5), 687–692 (2010).
   PubMed Web of Science ®Google Scholar
• Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the ‘hyperhemolysis paradigm’ for pulmonary hypertension from the perspective of evidence-based medicine. Am. J. Hematol.86(2), 123–154 (2011).
   PubMed Web of Science ®Google Scholar
• Parent F, Bachir D, Inamo J et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N. Engl. J. Med.365(1), 44–53 (2011).
   PubMed Web of Science ®Google Scholar
• Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF. Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease. Eur. Respir. J. doi:10.1183/09031936.00134410 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet376(9757), 2018–2031 (2010).
   PubMed Web of Science ®Google Scholar
• Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum.52(12), 3792–3800 (2005).
   PubMed Web of Science ®Google Scholar
• Anthi A, Machado RF, Jison ML et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am. J. Respir. Crit. Care Med.175(12), 1272–1279 (2007).
   PubMed Web of Science ®Google Scholar
• Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur. Respir. J.34(4), 888–894 (2009).
   PubMed Web of Science ®Google Scholar
• Kovacs G, Maier R, Aberer E et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am. J. Respir. Crit. Care Med.180(9), 881–886 (2009).
   PubMed Web of Science ®Google Scholar